Antibe Therapeutics Faces Receivership and Delisting - TipRanks.com - TipRanks
ATBPF Stock | USD 0.22 0.00 0.00% |
Roughly 56% of Antibe Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Antibe Therapeutics pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Antibe Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Antibe Therapeutics stock news signals to limit their universe of possible portfolio assets.
Antibe Therapeutics pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Antibe daily returns and investor perception about the current price of Antibe Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Antibe |
Antibe Therapeutics Faces Receivership and Delisting - TipRanks.com TipRanks
Read at news.google.com
Antibe Therapeutics Fundamental Analysis
We analyze Antibe Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Antibe Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Antibe Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Antibe Therapeutics is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Antibe Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Antibe Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Antibe Therapeutics could also be used in its relative valuation, which is a method of valuing Antibe Therapeutics by comparing valuation metrics with similar companies.
Peers
Antibe Therapeutics Related Equities
ANEB | Anebulo Pharmaceuticals | 7.64 | ||||
ADAG | Adagene | 6.39 | ||||
PEPG | PepGen | 6.37 | ||||
RZLT | Rezolute | 4.90 | ||||
PHVS | Pharvaris | 3.29 | ||||
MOLN | Molecular Partners | 2.04 | ||||
AVTE | Aerovate Therapeutics | 1.50 | ||||
MNOV | MediciNova | 3.36 | ||||
PMVP | Pmv Pharmaceuticals | 4.73 | ||||
HCWB | HCW Biologics | 9.80 |
Complementary Tools for Antibe Pink Sheet analysis
When running Antibe Therapeutics' price analysis, check to measure Antibe Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antibe Therapeutics is operating at the current time. Most of Antibe Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antibe Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antibe Therapeutics' price. Additionally, you may evaluate how the addition of Antibe Therapeutics to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |